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Altering the number of surface receptors can rapidly modulate cellular responses to extracellular signals. Some receptors,
like the transferrin receptor (TfR), are constitutively internalized and recycled to the plasma membrane. Other receptors,
like the epidermal growth factor receptor (EGFR), are internalized after ligand binding and then ultimately degraded in
the lysosome. Routing internalized receptors to different destinations suggests that distinct molecular mechanisms may
direct their movement. Here, we report that the endosome-associated protein hrs is a subunit of a protein complex
containing actinin-4, BERP, and myosin V that is necessary for efficient TfR recycling but not for EGFR degradation. The
hrs/actinin-4/BERP/myosin V (CART [cytoskeleton-associated recycling or transport]) complex assembles in a linear
manner and interrupting binding of any member to its neighbor produces an inhibition of transferrin recycling rate.
Disrupting the CART complex results in shunting receptors to a slower recycling pathway that involves the recycling
endosome. The novel CART complex may provide a molecular mechanism for the actin-dependence of rapid recycling of
constitutively recycled plasma membrane receptors.
INTRODUCTION
Endocytosis is required for the uptake of essential nutrients
from the extracellular environment as well as for retrieval of
proteins and lipids that are added to the plasma membrane
during fusion of regulated and constitutive secretory vesi-
cles (De Camilli and Takei, 1996; Koenig and Ikeda, 1996;
Robinson et al., 1996; Mukherjee et al., 1997; Schmid, 1997;
Betz and Angleson, 1998; Koenig et al., 1998; Stoorvogel,
1998; D’Hondt et al., 2000; Gruenberg, 2001). The endocytic
pathway can be separated into numerous stages based on
the movement of cargo and the identification of morpholog-
ically defined compartments (De Camilli and Takei, 1996;
Koenig and Ikeda, 1996; Robinson et al., 1996; Mukherjee et
al., 1997; Schmid, 1997; Betz and Angleson, 1998; Koenig et
al., 1998; Stoorvogel, 1998; D’Hondt et al., 2000; Gruenberg,
2001). Early events in the endocytic process include mem-
brane invagination and vesicle budding from the plasma
membrane, formation of transport vesicles, and fusion with
early endosomes. Later events include cargo sorting, and
additional transport/fusion steps, including those responsi-
ble for transport to the lysosome for degradation, and those
responsible for recycling back to various compartments (De
Camilli and Takei, 1996; Koenig and Ikeda, 1996; Robinson et
al., 1996; Mukherjee et al., 1997; Schmid, 1997; Betz and
Angleson, 1998; Koenig et al., 1998; Stoorvogel, 1998;
D’Hondt et al., 2000; Gruenberg, 2001). Although much
progress has been made in elucidating the molecular pro-
cesses involved in early endocytic events, such as those
involved in the genesis of clathrin-coated endocytic trans-
port vesicles, an equally clear understanding of later events
remains elusive.
The early endosome is a crucial point in the endocytic
pathway to sort cargo for transport to late endosomes for
eventual degradation in the lysosome, or for recycling to the
plasma membrane (Hopkins et al., 1985; Gruenberg and
Maxfield, 1995; Ward et al., 1995). The early endosome is
composed of at least two forms, including the vacuolar or
tubulovesicular endosome, containing early endosome anti-
gen 1 (EEA1) and rab 5, as well as the recycling endosome,
containing rab 11 (Hopkins et al., 1985; Gorvel et al., 1991;
Gruenberg and Maxfield, 1995; Ward et al., 1995; Ullrich et
al., 1996; Trischler et al., 1999). Recycling of cargo to the
plasma membrane occurs from both early endosomal com-
partments as can transport to late endosomes (Hopkins et al.,
1985; Gorvel et al., 1991; Ward et al., 1995; Ullrich et al., 1996;
Trischler et al., 1999; Gruenberg, 2001). It is likely that a
combination of maturation and vesicular transport mecha-
nisms allows for tight control of the sorting, transport, and
recycling functions in the early endosomal compartment
(Gruenberg, 2001). Routing internalized receptors to differ-
ent destinations suggests that distinct molecular mecha-
nisms are required to direct their movement.
A role for the actin cytoskeleton in endocytosis has been
controversial (Qualmann et al., 2000; Engqvist-Goldstein and
Drubin, 2003). In yeast, mutations in actin or fimbrin inhibit
endocytosis (Kubler and Riezman, 1993). Additionally, ge-
netic screens for mutants affecting endocytosis have re-
vealed mutations in several genes that disrupt both endocy-
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tosis and actin organization (Benedetti et al., 1994; Munn et
al., 1995; Tang et al., 1997). However, some yeast mutants
that disrupt actin organization have no effect on endocytosis
(Riezman et al., 1997), and some suppressors of an endocy-
tosis mutant that also affects actin organization (end5) can
rescue one or the other phenotype, but not both, suggesting
that they are separable (Riezman et al., 1997). In mammalian
cells, many reports exist describing the necessity, or lack
thereof, of the intact actin cytoskeleton for endocytosis
(Durrbach et al., 1996; Lamaze et al., 1997; Fujimoto et al.,
2000; Qualmann et al., 2000; Taunton et al., 2000; Lanzetti et
al., 2001; Zaslaver et al., 2001). These reports have concen-
trated on the effect of disruption of the integrity of the actin
cytoskeleton on early events in the endocytic process such as
vesicle budding from the plasma membrane, but they have
not focused on later events such as the motility of endo-
somes. GFP-actin tails occur on newly pinched off pino-
somes in RBL cells and have been proposed to move these
organelles from the membrane into the cell (Merrifield et al.,
1999). Actin tails also associate with endosomes in a cell-free
system (Moreau and Way, 1998; Taunton et al., 2000). These
data suggest a role for the actin cytoskeleton in the motility
of endosomes after initial endocytic events. Thus, although
endosomes associate with the actin cytoskeleton and this asso-
ciation is likely involved in endosome motility (Durrbach et al.,
1996; Lamaze et al., 1997; Nakagawa and Miyamoto, 1998;
Qualmann et al., 2000; Gruenberg, 2001; Lanzetti et al., 2001),
the precise role of the actin cytoskeleton in endocytosis is
unclear.
Hrs is a mammalian protein, predominantly localized on
early endosomes (Komada et al., 1997; Tsujimoto et al., 1999),
that physically interacts with a number of proteins, includ-
ing eps15 (Bean et al., 2000), SNX-1 (Chin et al., 2001), TSG101
(Pornillos et al., 2003), and SNAP-25 (Bean et al., 1997),
previously implicated in membrane trafficking. Hrs has ho-
mologues in insects (Lloyd et al., 2002) and fungi (Raymond
et al., 1992). Deletion or mutation of hrs results in an en-
larged endosomal phenotype in mouse (Komada and Sori-
ano, 1999), fly (Lloyd et al., 2002), and yeast (Raymond et al.,
1992). This suggests that hrs deletion may decrease efflux
from early endosomes to certain destinations (e.g., the
plasma membrane) and that hrs may play a role in cargo
sorting and/or endosomal trafficking at the early endosome.
Here, we report that the endosome-associated protein hrs
is a subunit of the cytoskeleton-associated recycling or trans-
port (CART) complex that also contains actinin-4, BERP, and
myosin V. The CART complex is necessary for efficient
recycling of the transferrin (Tf) receptor to the plasma mem-
brane, but not movement to lysosomes and degradation of
the EGFR. These results not only identify the CART complex
but also support a model that describes how sorting endo-
somes are linked with the actin cytoskeleton to enable effi-
cient retrieval of constitutively recycled receptors to the
plasma membrane.
MATERIALS AND METHODS
Antisera and DNA Constructs
A rabbit was immunized with a peptide (MGDYMAQEDDWC) that had been
coupled to keyhole limpet hemocyanin and corresponds to the first 11 amino
acids of the actinin-4 protein (Honda et al., 1998). This region of actinin-4 has
limited homology with sequences of other actinins (Honda et al., 1998) and
has been used previously to produce specific actinin-4 antisera (Honda et al.,
1998). The resulting serum was affinity purified and used for immunohisto-
chemistry and Western blotting. The myosin Vb antibody was obtained from
J. Leonard (University of Massachusetts Medical School, Worcester, MA);
BERP, N-BERP, and rat myosin Vb (myr6) constructs were obtained from S. R.
Vincent (University of British Colombia, Vancouver, BC, Canada); and
pBKactinin-4 was obtained from T. Yamada and S. Hirohashi (National
Cancer Center Research Institute, Tokyo, Japan). Other DNA constructs and
antibodies are described here.
Immunohistochemistry
HeLa cells were maintained in DMEM (Mediatech, Herndon, VA) supple-
mented with 10% (vol/vol) fetal bovine serum (FBS) (Equitech-Bio, Ingham,
TX). Cells were plated 1 d before experiments. Cells with or without drug
treatment were washed three times with phosphate-buffered saline (PBS) and
fixed with 4% paraformaldehyde at room temperature for 10 min. Fixed cells
were then extracted with 0.2% Triton X-100 (vol/vol) (in 0.1 M phosphate
buffer, pH 7.4) for 1 min (4°C) and washed three times with PBS before
immunolabeling. For immunolabeling, cells were incubated with primary
antibodies in 0.1 mM phosphate buffer, pH 7.4 containing 2% normal goat
serum and 0.25% saponin overnight at 4°C. After washing three times with
PBS, the cells were incubated with secondary antibodies at 37°C for 30 min.
After washing as described above, coverslips were mounted with para-
phenylenediamine in 50% glycerol/0.1 M phosphate buffer, pH 7.4.
The antibodies used in this study and their dilutions used for immunohis-
tochemistry were rabbit anti-actinin-4 (described above), 1:100; rabbit anti-
actin (recognizing both F- and G-actin (Sigma-Aldrich, St. Louis, MO), 1:100;
rabbit anti-Eps15 (Santa Cruz Biotechnology, Santa Cruz, CA), 1:200; rabbit
anti-EEA1 (BD Biosciences Transduction Laboratories, San Diego, CA), 1:200;
mouse anti--actinin-1 (Sigma-Aldrich), 1:200; and mouse anti-transferrin
receptor (Santa Cruz Biotechnology), 1:50. The secondary antibodies were
Alexa 488-labeled goat anti-mouse IgG, dichlorotriazin amino fluorescein-
labeled goat anti-mouse IgG, Alexa 594 goat anti-mouse IgG, Texas Red-
labeled donkey anti-rabbit IgG, and Alexa 488-labeled donkey anti-rabbit IgG.
All secondary antibodies were purchased from Molecular Probes (Eugene,
OR) and were used at a 1:1000 dilution. Fluorescence images were acquired
using a Zeiss Axiovert microscope with a Hamamatsu ORCA charge-coupled
device (CCD) camera and viewed using MetaView software (Universal Im-
aging, Downingtown, PA).
Immunogold Electron Microscopy
HeLa cells were fixed in 2% paraformaldehyde and 0.2% glutaraldehyde in
0.1 M PHEM buffer (0.2 M, containing 240 mM PIPES, 100 mM HEPES, 8 mM
MgCl2, and 40 mM EGTA, pH 6.9) containing paraformaldehyde (2%) and
glutaraldehyde (0.2%) for 2 h at room temperature. Fixed cells were stored as
pellets in PHEM (0.1 M) and paraformaldehyde (0.5%) at 4°C until they were
processed for ultrathin cryosectioning and immunolabeling according to the
protein A-gold method (Slot et al., 1991). Briefly, fixed cells were washed with
0.02 M glycine in PBS, scraped gently from the dish in PBS with 1% gelatin,
and pelleted in 12% gelatin in PBS. The gelatin cell pellet was solidified on ice
and cut into small blocks. For cryoprotection, blocks were infiltrated over-
night with 2.3 M sucrose at 4°C and mounted on aluminum pins then frozen
in liquid nitrogen. Ultrathin cryosections with an average thickness of 60 nm
were cut with a diamond knife (Diatome, Biel, Switzerland) at 120°C and
picked up in a 1:1 mixture of 2.3 M sucrose and 1.8% methyl cellulose in
distilled water (Liou et al., 1996). The sections were thawed to room temper-
ature, incubated with primary antibodies (rabbit anti-actinin-4, 1:30 or mouse
monoclonal anti-Hrs, 1:100 [Axxora, San Diego, CA]; 1 h, room temperature)
and protein A coupled to 15-nm-gold particles (University Medical Centre of
Utrecht, Utrecht, The Netherlands). For the Hrs labeling rabbit anti-mouse
IgG antibodies (Pierce Chemical, Rockford, IL) were used as bridging anti-
bodies before applying the protein A-gold. Negative controls included label-
ing without primary antibodies. Finally, sections were contrasted and embed-
ded within a mixture of 0.4% uranylacetate in 2% methyl cellulose, after
which they were examined in a Tecnai 12 transmission electron microscope
(FEI, Eindhoven, The Netherlands). Photographic negatives of light micro-
scopic and electron microscopic images were digitized with an Epson Perfec-
tion 2450 scanner.
For morphometric quantification, the distribution of total gold particles on
50 cell profiles for actinin-4 and 30 for hrs, respectively, were counted at
20,000 magnification and divided into the following eight subcellular com-
partments proved relevant for their distribution: 1) plasma membrane (i.e.,
gold particles within the distance of 20 nm of the membrane); 2) filopodia (i.e.,
actin-rich cellular extensions from plasma membrane); 3) terminal web under
plasma membrane (actin-rich region200 nm beneath the plasma membrane;
4) early/recycling endosomes; 5) late endosomes/lysosomes; 6) Golgi/trans-
Golgi network (TGN); 7) endoplasmic reticulum (ER); and 8) other.
Two-Hybrid Screen
Full-length hrs was subcloned into the pGBT vector and used to screen a
human brain cDNA library inserted downstream of the GAL4 activation
domain in the pGAD10 vector (BD Biosciences Clontech, Palo Alto, CA) as
described previously (Bean et al., 2000). Twelve days after plating, large
colonies (3 mm in diameter, n  190) were replica plated onto new plates
and -galactosidase activity was assessed on filter lifts. Single colonies from
clones that turned blue within 1 h (n  40) were grown overnight in SD
medium lacking leucine, tryptophan, and histidine and DNA was extracted.
DNA was electroporated into HB101 Escherichia coli cells, and DNA was
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isolated from single colonies. After restriction digests confirmed the presence
of the activation domain plasmid, multiple cotransformations were per-
formed with the candidate DNA and the pGBT9/h, as well as pGBT9/p53.
Clones that reacted positively for -galactosidase activity with the pGBT9/h
but not either by themselves or with the control plasmids containing the
binding domain alone or the binding domain fused to the tumor suppressor
gene p53, were considered for further study (n  36).
In Vitro Binding Assay
The His-tagged hrs fusion protein and all glutathione S-transferase (GST)
fusion proteins were prepared as described previously (Tsujimoto and Bean,
2000). GST-fused proteins were cleaved from the GST moiety by using throm-
bin (7.5 U/ml; Amersham Biosciences, Sunnyvale, CA) at room temperature
for 2–4 h. The cleavage reaction was stopped by adding 0.1 mM phenylmeth-
ylsulfonyl fluoride. All soluble proteins were precleared with glutathione-
agarose before quantitation and binding. Protein concentrations were esti-
mated by Coomassie Blue stain following SDS-PAGE by using bovine serum
albumin (BSA) as a standard.
To identify the region of hrs responsible for actinin-4 binding, a cleaved
GST-fusion of actinin-4(359–913) and increasing concentrations of various GST-
fused hrs fragments immobilized on glutathione-agarose beads were incu-
bated in binding buffer (20 mM HEPES, pH 7.4, 150 mM KCl, and 0.05%
Tween 20) for 1 h at 4°C. Beads were washed three times with buffer con-
taining 0.1 M PBS and 0.05% Tween 20, solubilized in 12 l of SDS sample buffer,
and separated by SDS-PAGE. The bound actinin-4 was detected by immunoblot
analysis by using enhanced chemiluminescence (Pierce Chemical).
To quantify the binding of hrs and actinin-4, 0.06 M GST-actinin-4 was
immobilized and incubated with various concentrations of purified soluble
hrs. After resolution by SDS-PAGE, the bound hrs was detected by immuno-
blot with 125I-conjugated secondary antibody. The hrs bands on the phospho-
rimage were subjected to a quantitation with IQMac software (version 1.2;
Amersham Biosciences). Hrs did not bind to GST alone (our unpublished
data).
To examine the inhibition of actinin-4/h binding by hrs or actinin-4 frag-
ments, we incubated hrs (0.5 M, 4°C for 1 h) and immobilized GST-actinin-4
(0.1 M) with purified hrs(1–449) or actinin-4357–469 (8:1 M ratio) (4°C for 1 h).
The hrs that remained bound to actinin-4 in the presence and absence of hrs
or actinin-4 fragments was detected by immunoblot with 125I-conjugated
secondary antibody after SDS-PAGE and quantified by phosphorimaging as
described above.
Cell Culture and Transfection
HeLa cells were cultured as a monolayer in 10-cm plastic plates in DMEM
containing 10% FBS under 5% CO2 at 37°C. Before each experiment, cells were
split with trypsin/EDTA and seeded in six-well tissue culture plates.
Plasmid DNA was prepared (QIAGEN, Hilden, Germany) for the transfec-
tion of HeLa cells. Transient transfections of plasmid DNA were performed
(Effectene transfection kit, QIAGEN) on HeLa cells according to the manu-
facturer’s protocol. The constructs used in each transfection are as indicated.
Cells remained in growth medium with the transfection mixture for 4 h and
were subsequently washed three times with fresh media and incubated
overnight in conditioned media before use.
For trafficking studies in which hrs(1–449) was expressed, HeLa cells were
first infected with recombinant vaccinia virus (vT7) bearing the T7 RNA
polymerase gene. Vaccinia virus stock was trypsinized at 37°C for 30 min
with vigorous vortexing every 5–10 min, and then 10 l was added to HeLa
cells (de Bernard et al., 1997). After infection for 30 min at 37°C, the virus stock
was removed, and HeLa cells were transfected with pCDNA3-myc-hrs(1–449)
or the pCDNA3 vector. Cells were incubated for 4 h at 37°C, after which time
the transfection reagent was removed. The cells were washed twice with PBS
and incubated for 20 h before beginning trafficking assays.
Actinin-4 Depletion by Using RNA Interference
Duplexes of RNA oligonucleotides targeting human actinin-4 were designed
as 21 nucleotide RNAs and were chemically synthesized (Dharmacon Re-
search, Boulder, CO) The sequences of each RNA pair were as follows:
actinin-4, 5-AAG CAG CAG CGC AAG ACC UUC dTdT-3 and scrambled
(control), 5-CAG UCG CGU UUG CGA CUG GdTdT. RNA oligonucleotides
were transfected (Oligofectamine; Invitrogen, Carlsbad, CA) into 40–50%
confluent HeLa cells. A second transfection was performed 24 h after the first.
Trafficking was assessed 24 h after the second transfection, and the efficiency
of the depletion was analyzed by quantitative Western blotting using 125I-
secondary antibodies and phosphorimage analysis.
125I-Epidermal Growth Factor Trafficking
After transfection of HeLa cells with either duplexed RNA oligonucleotides,
pCDNA3-myc-hrs(1–449), pCDNA3-myc-actinin-4357–469, or controls (scram-
bled RNA duplexes or pCDNA3 vector), cells were starved (medium A, 1%
BSA in DMEM, 60 min at 37°C), labeled with 125I-epidermal growth factor (1
ng/ml) for 30 min at 37°C, and then rinsed with cold medium A twice, acidic
solution (0.15 M NaCl and 0.1 M glycine, pH 3.0) twice, and once again with
medium A. Cells were chased with medium A for the indicated times. The
media and cells were collected at each time point. Cells were harvested by
scraping with 1 M NaOH. Proteins in the media were precipitated (20%
trichloroacetic acid [TCA]), and cells (internalized EGF), media pellet (recy-
cled EGF), and media supernatant (degraded EGF) were counted in a gamma
counter. Each data point was collected in duplicate. Recycled 125I-epidermal
growth factor was expressed as the ratio of recycled 125I-epidermal growth
factor versus internalized 125I-epidermal growth factor. Degraded 125I-epider-
mal growth factor was expressed as the ratio of degraded 125I-epidermal
growth factor versus internalized 125I-epidermal growth factor. The data were
corrected for nonspecific cell-associated 125I-epidermal growth factor (10%)
as determined in parallel experiments in which an excess (200 ng/ml) of
unlabeled EGF was present during labeling. Kinetic parameters were ob-
tained by fitting data with a linear regression over time. Bar graphs present
mean slopes obtained by regression analysis. Differences between rates were
analyzed using a Student’s t test.
125I-Transferrin Trafficking
Tf (Sigma-Aldrich) was saturated with Fe3 and labeled with 125I by using
iodo-beads (Pierce Chemical) according to the manufacturer’s procedures.
After transfection of HeLa cells with either duplexed RNA oligonucleotides,
pCDNA3-myc-hrs(1–449), pCDNA3-myc-actinin-4357–469, or controls (scram-
bled RNA duplexes or pCDNA3 vector), cells were starved (medium A, 1%
BSA in DMEM, 60 min at 37°C). To examine Tf recycling and degradation,
cells are labeled with 125I-transferrin (1 g/ml) for 30 min at 37°C and then
rinsed once with cold medium A, once with acidic solution (0.15 M NaCl and
0.1 M glycine, pH 3.0), and once again with medium A. Cells were chased
with medium A for the indicated times. The media and cells were collected at
each time point. Cells were harvested by scraping with 1 M NaOH. Proteins
in the media were precipitated (20% TCA), and cells (internalized transferrin),
media pellet (recycled transferrin), and media supernatant (degraded trans-
ferrin) were counted in a gamma counter. Each data point was collected in
duplicate. Recycled 125I-Tf was expressed as the ratio of recycled 125I-Tf
versus internalized 125I-Tf over time. The data were corrected for nonspecific
cell-associated 125I-Tf (10%) as determined in parallel experiments in which
an excess (200 g/ml) of unlabeled Tf was present during labeling. Kinetic
parameters were obtained by fitting data with a linear regression over time.
Bar graphs present mean slopes obtained by regression analysis. Differences
between rates were analyzed using a Student’s t test.
Transferrin-Alexa 594 Trafficking
After transfection of HeLa cells with either duplexed RNA oligonucleotides
specific for actinin-4 or scrambled oligonucleotides, cells were starved (me-
dium A, 1% BSA in DMEM, 60 min at 37°C) and then incubated with Alexa
594-transferrin (5 g/ml, 60 min at 0°C). The cells were washed three times
with medium A and transferred to a 37°C incubator for 10 min before
washing once with medium A, then with acidic solution (0.15 M NaCl and 0.1
M glycine pH 3.0), followed by another wash with medium A. Some cells
(0-min time point) were immediately fixed (4% paraformaldehyde at 0°C);
other cells were incubated in media A for 30 min before fixation (30 min time
point). Cells were examined using epifluorescence and images were obtained
using a Zeiss Aviovert microscope with a Hamamatsu ORCA CCD camera
and optimized with MetaMorph software (Universal Imaging).
RESULTS
Hrs Interacts with Actinin-4
We identified an interaction between hrs and actinin-4, an
actin binding protein, in a yeast two-hybrid screen. Acti-
nin-4 transiently associates with both macropinosomes and
phagosomes, structures that perform endocytic functions
(Araki et al., 2000). Actin filaments associate with endosomes
(Pol et al., 1997; Nakagawa and Miyamoto, 1998), suggesting
a role for this molecule in endocytosis. To confirm the inter-
action between hrs and actinin-4 observed in the two-hybrid
screen, we performed binding experiments that showed re-
combinant hrs and actinin-4 interact in a saturable manner
in the absence of other proteins (Figure 1A). The affinity of
hrs for immobilized actinin-4 (the concentration of protein at
which half-maximal binding occurs (EC50) was 0.4 M.
The apparent stoichiometry based on recombinant protein
binding experiments was 0.1–0.5:1 (actinin-4:hrs).
The interaction of hrs and actinin-4 also was observed
after antibodies specific for hrs coimmunoprecipitated both
hrs and actinin-4 from rat brain extracts (Figure 1B, lane 2) or
HeLa cells (Figure 1B, lane 3). The domain of hrs required
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for the interaction with actinin-4 was determined by examining
the binding of hrs fragments to actinin-4 (Figure 1C). The
minimal fragment of hrs necessary and sufficient for actinin-4
binding consists of amino acids 1–449 (Figure 1C, lane 4). The
FYVE or the VHS domains within the N-terminal region of hrs
were not sufficient for actinin-4 binding (Figure 1C, lanes 1 and
2). These data suggest that actinin-4 binding to hrs does not
require the helical coiled coil regions and imply that the tertiary
structure of the N-terminal region of hrs is an actinin-4 binding
determinant. The domain of actinin-4 required for hrs interac-
tion was identified based on overlapping fragments of acti-
nin-4 obtained in our two-hybrid screen. Four independent
clones [22-1 (identical to 359–911 of human actinin-4), 47-2
(359–911 of actinin-4), 52-1 (233–416 of actinin-4), and 123-8
(232–412 of actinin-4)] were isolated in our screen. These data
suggested that the minimal domain of actinin-4 necessary for
hrs binding is contained within the central coiled region
(amino acids 359–412).
Hrs and Actinin-4 Are Localized on Early Endosomes
To understand a cellular basis for the hrs/actinin-4 interac-
tion, we have examined the ultrastructural localization of
both hrs and actinin-4 in HeLa cells by using hrs (Tsujimoto
et al., 1999) and actinin-4 specific antibodies. The actinin-4
antisera labeled a single protein of 100 kDa on an immu-
noblot of HeLa cell lysate, which was completely blocked
after preincubation of the antisera with the immunogen
peptide (our unpublished data). Furthermore, Western anal-
ysis of this antisera revealed no cross-reactivity with other
actinins (our unpublished data). Hrs localizes both in the
cytoplasm and on the cytoplasmic face of endosomal mem-
branes (Figure 2A). In addition to hrs, we also detected
actinin-4 on endosomal membranes (Figure 2B). Quantifica-
tion of gold particles on various organelles confirmed that
hrs labeling was found predominantly associated with early
endosomes but also on the actin-rich terminal web region
(200 nm beneath the plasma membrane) and the late en-
dosomes/lysosomes, with some labeling on the plasma
membrane (Figure 2E). Actinin-4 labeling was found pre-
dominantly associated with the terminal web and early en-
dosomes, with some labeling of filopodia and on the plasma
membrane (Figure 2C,D,E). These data suggested that early
endosomes contained a significant overlap in the localiza-
tion of hrs and actinin-4.
Actinin-4 Depletion Affects Tf Trafficking
Endosomes or endocytic transport vesicles likely use cy-
toskeletal elements for motility (Durrbach et al., 1996; Naka-
gawa and Miyamoto, 1998; Durrbach et al., 2000; Neuhaus
and Soldati, 2000; Lanzetti et al., 2001; Lapierre et al., 2001;
Zaslaver et al., 2001; Shupliakov et al., 2002; Engqvist-Gold-
stein and Drubin, 2003). Actinin-4 is predicted to have an
actin-binding domain, and we have observed that it binds
actin (our unpublished data). We hypothesized that the
hrs/actinin-4 interaction may play a role in actin-associated
trafficking of endosomes. We tested this notion and exam-
ined how depletion of actinin-4 affects the trafficking of
endocytic cargo. We determined the kinetics of 125I-epider-
mal growth factor receptor and 125I-Tf receptor internaliza-
tion, recycling, and degradation in cells that had been de-
pleted of actinin-4 by RNA interference (Figure 3).
Transfection of HeLa cells with RNA duplexes resulted in an
87 	 13% decrease in actinin-4 levels (Figure 3A, lane 2),
whereas other actinin isoforms remained present in these
cells (Figure 3A, lane 4). There was no significant alteration
in actin, hrs, or eps15 levels (Figure 3A, lanes 5–7). Further-
more, no alterations in the localization or morphology of
early endosomes or actin filaments were evident after de-
pletion of actinin-4 (Figure 3A, right). Depletion of actinin-4
had no significant effect on the internalization of Tf or EGF
or the degradation of Tf (our unpublished data) nor were
there significant differences in plasma membrane Tf versus
Figure 1. Hrs binds directly to actinin-4 through distinct domains.
(A) Recombinant hrs was incubated with immobilized actinin-4,
washed, eluted, separated by SDS-PAGE, and bound hrs was quan-
titated using 125I-secondary antibody and phosphorimaging. The
EC50 is0.4 M, and the stoichiometry is 0.1–0.5–1.0, depending on
which protein is immobilized. A Ponceau S stain of actinin-4 is
shown for a loading control. (B) Actinin-4 coimmunoprecipitates
with hrs. Rat brain postnuclear supernatant (lane 4) was incubated
with purified mouse IgG (lane 1) or a monoclonal anti-hrs (lanes 2
and 3). Hrs and actinin-4 also were coimmunoprecipitated from
HeLa cell lysate (lane 3). (C) Seven GST-hrs fusion proteins (desig-
nated 1–7) were immobilized on glutathione-agarose and assayed
for binding to actinin-4(359–913) as in A. These results identify a
specific domain in hrs essential for its interaction with actinin-4.
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total cellular Tf at time points before recycling (0–3 min) in
actinin-4 depleted cells versus control cells. However, acti-
nin-4 depletion inhibited the rate of Tf recycling by 63.6 	
2.8% with no significant effect on the EGF recycling or deg-
radation rate (Figure 3B). These data suggested that actinin-4
plays a role in efficient recycling of the Tf receptor.
The reduction in Tf recycling by depletion of actinin-4 was
not accompanied by an alteration in its degradation. This
suggested that reduction in the rate of recycling reflected an
alteration in the trafficking of recycling cargo. We examined
the localization of internalized Tf-Alexa 594 after cells were
transfected with either control (scrambled) or actinin-4-spe-
cific RNA duplexes (Figure 3C). In the presence of actinin-4,
Tf moved through the recycling endosome and seemed to be
largely recycled after a 30 min chase period, consistent with
previous data (Hopkins and Trowbridge, 1983; Hopkins et
al., 1985; Mayor et al., 1993; Sheff et al., 2002). In contrast,
Tf-Alexa 594 was concentrated in the recycling endosome
after 30 min in cells lacking actinin-4 (Figure 3C). This sug-
gested that the decreased recycling rate observed after de-
pletion of actinin-4 likely reflected either decreased egress or
rate of movement from the early endosome to the recycling
endosome. Equally probable is that a greater percentage of
Tf took the longer route through the recycling endosome
because the pathway for direct recycling from the early
endosome was inhibited. Thus, the reduction in rate of
recycling after actinin-4 depletion reflected an alteration in
the trafficking of recycling cargo, perhaps by diverting it
through a longer recycling pathway.
Disruption of Hrs/Actinin-4 Binding Affects Tf Trafficking
Because hrs(1–449) was the minimal fragment required for
actinin-4 binding (Figure 1C) and we deduced the actinin-4
binding site to be actinin-4(359–412) (based on the minimal
interacting fragment of actinin-4 found in our two-hybrid
screen), we tested whether these regions might inhibit the
binding of full-length hrs to actinin-4. In the presence of
increasing amounts of hrs(1–449) or actinin-4(357–469), the
binding of hrs to actinin-4 was reduced as much as 99%,
which was likely due to competition with full-length hrs for
actinin-4 binding (our unpublished data). The role of the hrs/
actinin-4 interaction was probed by expressing the fragment of
Figure 2. Hrs and actinin-4 are localized
on early endosomes. Ultrathin cryosections
of HeLa cells were labeled with specific hrs
and actinin-4 antisera and visualized with
15-nm gold particles conjugated to protein
A. (A) Hrs is mostly found associated with
early endosomal vacuoles and recycling tu-
bules. Actinin-4 (B and C) is occasionally
found associated with early endosomal
vacuoles, but it is predominantly enriched
to the proximity to the plasma membrane
(D), at the actin-rich terminal web within
200 nm of the plasma membrane and the
filopodial extensions. Arrowheads indicate
the location of gold particles. ee, early en-
dosome; er, endoplasmic reticulum; g,
Golgi; pm, plasma membrane; n, nucleus.
Bars, 200 nm. (E) Quantitation of hrs and
actinin-4 labeling in eight subcellular com-
partments relevant for their distribution; in-
cluding the plasma membrane (i.e., label on
pm 	 20 nm), filopodia (i.e., actin rich cel-
lular extensions from plasma membrane),
terminal web under plasma membrane (ac-
tin-rich region 200 nm beneath the plasma
membrane), early/recycling endosomes,
late endosomes/lysosomes, Golgi/TGN,
ER, and all other particles.
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hrs or actinin-4 required for hrs/actinin-4 binding (Figure 4B)
in HeLa cells and then examining the trafficking of 125I-epider-
mal growth factor and 125I-Tf. Expression of hrs1–449 blocked
the ability of actinin-4 to be precipitated with hrs (Figure 4A)
and inhibited the rate of Tf recycling by 67.7 	 3.1% (Figure
4C). Actinin-4357–469 also blocked the ability of actinin-4 to be
precipitated with hrs (Figure 4A) and inhibited the rate of Tf
recycling by 46.1 	 2.2% (Figure 4D) with no significant effect
on the EGF recycling or degradation rate (our unpublished
data). We observed no significant effect on the internalization
of Tf or EGF after expressing the hrs or actinin-4 fragments
hrs1–449 or actinin-4357–469 (our unpublished data). Thus, block-
ing the hrs/actinin-4 interaction by using fragments of either
hrs or actinin-4 produced the same effect as reducing the levels
of actinin-4, a marked inhibition of Tf recycling with no signif-
icant effect on EGF trafficking or Tf internalization. This sug-
gested that the hrs/actinin-4 interaction was required for effi-
cient recycling of Tf.
Actinin-4 Is Present in a Complex Containing Hrs, BERP,
and Myosin V
Sorting endosomes or vesicles that bud from this compart-
ment must move to the plasma membrane to recycle cargo.
It seems likely that this vectorial movement would involve
the cytoskeleton and a molecular motor that propels the
membrane compartment to the plasma membrane. Interest-
ingly, myosin Vb, a processive motor (Yildiz et al., 2003), is
present on early endosomes and is involved in receptor
recycling (Evans et al., 1997; Lapierre et al., 2001). Moreover,
myosin V binds to BERP (El-Husseini and Vincent, 1999), a
ring-finger protein of unknown function that also interacts
with actinin-4 (El-Husseini et al., 2000). We reasoned that an
hrs/actinin-4/BERP/myosin V protein complex could link
sorting endosomes with the actin cytoskeleton and enable
their motility for receptor recycling.
We first examined whether BERP was enriched on early
endosomes because its cellular location was unknown. HeLa
cell lysate contained the early endosomal marker protein
EEA1, as well as hrs, actinin-4, and BERP proteins (Figure
5A). Isolation of early endosomes that did not contain de-
tectable levels of the plasma membrane marker Na/K
ATPase, the ER marker calnexin, or the lysosomal marker
LAMP1 (Figure 5A) that are enriched for the endosomal
marker EEA1 and hrs (Yan et al., 2004) were also enriched in
actinin-4 and BERP, suggesting that BERP was present on
early endosomes (Figure 5A).
We next immunoprecipitated BERP from HeLa cells and
found that actinin-4, hrs, and myosin Vb were coprecipi-
Figure 3. RNA interference specifically depletes actinin-4 and in-
hibits transferrin receptor recycling. (A) Extracts from HeLa cells
transfected with either duplexed RNA oligonucleotides directed
against the actinin-4 sequence (Act-4RNAi) or a random RNA se-
quence (ContRNAi) were subjected to quantitative western-blots for
actinin-4 (lanes 1 and 2). The same samples were probed with a pan
actinin antibody that likely recognizes all actinin isoforms (lanes 3
and 4). Extracts also were probed with antibodies to actin, hrs, or
eps15 (lanes 5–7). Ponceau S staining shows equal protein loading.
HeLa cells were plated on coverslips (right), transfected with either
Act-4RNAi or ContRNAi, and probed with antibodies against EEA1,
actin, and actinin-4. Bar, 4 m. (B) Actinin-4 was depleted from
HeLa cells as described above. Cells were incubated with 125I-
epidermal growth factor or 125I-transferrin as described in Materials
Figure 3. (cont) and Methods. At each time point, the amount of Tf or
EGF internalized (Int.), recycled (Rec.), and degraded (Deg., EGF only)
was determined as described (see Materials and Methods). The ratio of
the amount of recycled or degraded to the amount internalized is
plotted over time for Tf and EGF. Histograms of the mean slope (rate)
of these ratios are shown for each condition (n  3). The rate of
recycling of transferrin was significantly inhibited by depletion of
actinin-4 (n  3, p  0.0021; recycling rate in actinin-4–depleted cells,
0.0051 	 0.0004; scrambled, 0.014 	 0.001). The rate of recycling and
degradation of EGF were not altered by depletion of actinin-4 (rate of
recycling: scrambled, 0.001, and actinin-4, 0.001, n  3; rate of degra-
dation: scrambled, 0.0052, and actinin-4, 0.0057, n  3). C. HeLa cells
transfected with either Act-4RNAi or ContRNAi were loaded with Tf-
Alexa594 at 0°C for 60 min then shifted to 37°C for 10 min (0). After 0-
or 30-min chase period the location of Tf-Alexa594 was determined.
Early endosomes (arrowheads alone) and perinuclear recycling endo-
somes (arrows) are indicated. The inset of the Act-4RNAi panel at 30 min
shows colocalization of the Tf receptor with Tf-Alexa 594. Bar, 16 m.
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tated (Figure 5B, lane 1). To further understand the nature of
this protein complex, we tested whether it would form by
using recombinant proteins (Figure 5C). Incubation of hrs,
actinin-4, and BERP with the tail domain of myosin V that
had been immobilized on agarose beads, but not on beads
with immobilized GST, revealed that a complex forms in the
absence of other components (Figure 5C, lane 1). Impor-
tantly, if BERP was immobilized, both actinin-4 and hrs
would bind (Figure 5C, lane 2), but if actinin-4 was immo-
bilized only hrs would bind (Figure 5C, lane 3). No complex
could form when the tail domain of myosin V was immo-
bilized and hrs and actinin-4 were added in the absence of
BERP, suggesting that BERP links myosin V with hrs and/or
actinin-4 (Figure 5C, lane 4). However, if the tail domain of
myosin V was immobilized and hrs and BERP were added
in the absence of actinin-4, then only BERP was bound to
myosin V (Figure 5C, lane 5), suggesting that hrs binds to
the complex via interacting with actinin-4.
BERP Links Actinin-4 to Myosin V and Is Required for Tf
Recycling
The CART complex, composed of hrs, actinin-4, BERP, and
myosin V, seemed to require BERP to link myosin V to
hrs/actinin-4. We examined the effect of the N-terminal
region of BERP (Figure 5E) that binds to actinin-4 but not to
myosin V, on the trafficking of 125I-epidermal growth factor
and 125I-Tf. Expression of N-BERP blocked the ability of
myosin Vb to coprecipitate actinin-4 (Figure 5D) and inhib-
ited the rate of Tf recycling by 49.5 	 7.7% (Figure 5F) with
Figure 4. Inhibition of hrs/actinin-4 interaction reduces the rate of transferrin recycling. (A) Expression of hrs(1–449) or actinin-4(357–469)
inhibits the interaction of hrs and actinin-4 in situ. Immunoprecipitation of endogenous hrs coprecipitates actinin-4 in wt control HeLa cells
(lane 1), whereas expression of either actinin-4(357–469) (lane 2) or hrs(1–449) (lane 3), but not N-BERP (lane 4) inhibited the coprecipitation.
Moreover, eps15 was coprecipitated with hrs under all conditions. Mouse IgG did not precipitate any proteins. (B) The hrs(1–449) fragment
was expressed in HeLa cells as described in Materials and Methods. The fate of both transferrin and EGF was then determined and represented
as in Figure 3. (C) Schematic representation of the domain structure of actinin-4 with the region required for hrs binding (binds hrs), and a
depiction of the region used to inhibit hrs/actinin-4 binding (actinin-4357–469). Expression of hrs(1–449) also significantly inhibited transferrin
recycling (rate of control is 0.0096 	 0.0012, hrs(1–449) is 0.0031 	 0.0003, n  3, p  0.001). Expression of hrs(1–449) did not significantly affect
EGF recycling or degradation (recycling rate in control is 0.0012 	 5.77E-05, hrs(1–449) is 0.0013 	 8.82E-05, n  3; degradation rate in control
is 0.0047	 0.0003, hrs(1–449) is 0.0049	 0.0002, n 3). (D) The actinin-4(357–469) fragment was expressed in HeLa cells as described in Materials
and Methods. Expression of actinin-4(357–469) did not significantly affect EGF recycling or degradation (recycling rate in control, 0.0025 	
7.83E-05; actinin-4(357–469), 0.0018 	 1.09E-04, n  12; degradation rate in control, 0.0028 	 0.0001; actinin-4(357–469), 0.0021 	 0.0001, n  12).
The kinetics of transferrin recycling is shown (left) as is a bar graph representing the rate of transferrin recycling (right, recycling rate in
control, 0.0252 	 0.00036; actinin-4(357–469), 0.0136 	 0.000548). * denotes p  0.05.
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no significant effect on the EGF recycling or degradation rate
(our unpublished data). We observed no significant effect on
the internalization of Tf or EGF after expressing the N-BERP
fragment (our unpublished data).
DISCUSSION
The number of receptors and their residence time on the
plasma membrane are critical determinants for the response
Figure 5. The CART complex is formed in situ and in vitro, and BERP interactions are required for transferrin recycling. (A) BERP and
actinin-4 are enriched with early endosomal membranes. HeLa cell lysate and endosomal membranes were isolated as described previously
(Sun et al., 2003; Yan et al., 2004), separated on SDS-PAGE, and examined for the presence of BERP and actinin-4. The endosomal fractions
do not contain detectable Na/K ATPase, calnexin, LAMP1, or rab 7, but they are enriched for the early endosomal marker protein, EEA1.
(B) Immunoprecipitation of hrs from HeLa cell lysate. HeLa cells were transfected with myc-hrs, FLAG-BERP, and HIS-myosin V and
precipitated with either FLAG antisera (lane 1) or mouse IgG (lane 2). The precipitated material was separated by SDS-PAGE, and resulting
blots were probed with antisera against hrs, FLAG, actinin-4, and HIS. (C) Hrs, actinin-4, BERP, and myosin V interact in the absence of other
proteins and assemble in an ordered manner. Recombinant proteins were either immobilized on Sepharose or purified in a soluble form and
incubated in various combinations (as indicated). All proteins bound when incubated with immobilized myosin V (lane 1), actinin-4 and hrs
bound to immobilized BERP (lane 2), and hrs bound to immobilized actinin-4 (lane 3). Neither hrs nor actinin-4 bound to immobilized myosin
V in the absence of BERP (lane 4). Hrs did not bind to immobilized myosin V in the presence of BERP, but not actinin-4 (lane 5). None of
the recombinant proteins bound to immobilized GST (lane 6). (D) Expression of BERP (lane 3), but not N-BERP (lane 2), allowed
coprecipitation of actinin-4 with myosin Vb. Although BERP is seen in the lysate (lane 3), N-BERP is not seen in this lane because of
significantly smaller size. However, it was detected when separated on another gel, transferred, and probed with FLAG antibody (our
unpublished data). (E) The domain structure of BERP and the N-BERP fragment. (F) The N-terminal domain of BERP inhibits the rate of
transferrin recycling. Linear domain structure of BERP and N-BERP (top, see text for details). The N-terminal domain of BERP binds to
actinin-4, but not to myosin V, which allows the formation of the hrs/actinin-4/N-terminal BERP complex but inhibits association with
myosin V. In the presence of this BERP fragment, the transferrin recycling rate was significantly slowed. Tf recycling rates for the HeLa
control were 0.0180 	 0.0013 (n  6) and for N-BERP, 0.0091 	 0.0014 (n  6). * denotes p  0.05.
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of a cell to extracellular cues. Recycling is an efficient mech-
anism to ensure rapid delivery of receptors to the plasma
membrane and to regulate membrane dwell time. Although
much examination has resulted in a detailed view of the
internalization of plasma membrane receptors, the molecu-
lar mechanisms of their recycling are yet to emerge with the
same clarity. Recent results have suggested a role for myo-
sins in recycling (Neuhaus and Soldati, 2000; Lapierre et al.,
2001), implying a role for the actin cytoskeleton in this
process. Studies using drugs that depolymerize actin fila-
ments also implicate actin at a recycling step (Durrbach et al.,
1996; Cao et al., 1999; Zaslaver et al., 2001; Sheff et al., 2002;
Engqvist-Goldstein and Drubin, 2003). We have found that
an endosome-associated protein, hrs, is part of a protein
complex that includes actinin-4, BERP, and myosin Vb, des-
ignated CART. The CART complex is required for efficient
recycling of Tf receptors to the plasma membrane.
The interaction of an endosome-associated protein, hrs,
with actinin-4, a nonmuscle actin binding protein, was un-
expected. However, the hrs/actinin-4 interaction was ob-
served using the two-hybrid approach and confirmed by
both recombinant protein binding and immunoprecipitation
experiments. The interaction seems specific for actinin-4,
because other actinin isoforms were not found in the yeast
two-hybrid screen. Actinin-4 is a member of a protein family
that contains conserved structural and functional motifs.
These motifs include: an F-actin binding domain, a pleck-
strin homology domain containing a phosphatidylinositol
bisphosphate binding site, and two EF-hand calcium-bind-
ing domains (Honda et al., 1998). Little is known about the
function of actinin-4, although an actin-bundling activity is
suggested by the known activity of other actinin family
members (Honda et al., 1998). We have observed that acti-
nin-4 does indeed bind to filamentous actin and has bun-
dling, but not nucleation, activity (Lotfi and Bean, unpub-
lished observations). In macrophages, actinin-4 is transiently
associated with macropinosomes before their fusion with
lysosomes, as well as with phagosomes (Araki et al., 2000),
suggesting a role for this molecule in two mechanistically
similar types of endocytic trafficking (Racoosin and Swan-
son, 1993). Interestingly, the depletion of actinin-4 or disrup-
tion of hrs/actinin-4 interaction results in a decrease in Tf
recycling with no effect on EGF recycling or degradation and
no effect on internalization of either Tf or EGF. These data
suggest a specific role for actinin-4 and the hrs/actinin-4
interaction in receptor recycling from the early endosome to
the plasma membrane.
We considered the existence of an hrs/actinin-4/BERP/
myosin V complex based on the binary interactions between
hrs and actinin-4, actinin-4 and BERP (El-Husseini et al.,
2000), and BERP with myosin V (El-Husseini and Vincent,
1999). BERP is a ring-finger containing protein that interacts
with the tail domain of myosin V (El-Husseini and Vincent,
1999) through its C-terminal region and interacts with acti-
nin-4 through its N-terminal region (El-Husseini et al., 2000).
BERP may function as an adapter protein between actinin-4
that has bound to endosomes and myosin V because it is
enriched with endosomal membranes. Many ring finger-
containing proteins have ubiquitin ligase activity that would
be particularly interesting because receptor sorting is
thought to be regulated by this protein modification. We
have examined whether BERP is self-ubiquitinated or will
ubiquitinate proteins from E. coli lysate, although we have
not detected ligase activity with either potential substrate
(Lotfi and Bean, unpublished observations). The CART com-
plex most likely has an ordered assembly for its formation.
Specifically, the binding of actinin-4 to hrs is required for
BERP to bind and the binding of BERP to actinin-4 is re-
quired for myosin V to bind. Disruption of any of the binary
interactions comprising the quaternary complex inhibits Tf
recycling, as does disengaging myosin V from actin (La-
pierre et al., 2001). These data suggest that the CART com-
plex is required for a specific transport step necessary for
recycling to the plasma membrane.
A role for the actin cytoskeleton in endocytosis has been
controversial (Durrbach et al., 1996; Riezman et al., 1997;
Fujimoto et al., 2000; Qualmann et al., 2000; Gruenberg, 2001;
Engqvist-Goldstein and Drubin, 2003). In mammalian cells,
many reports describe the dependence or independence of
an intact actin cytoskeleton for early endocytic events such
as internalization (Durrbach et al., 1996; Cao et al., 1999;
Fujimoto et al., 2000; Qualmann et al., 2000; Gruenberg, 2001;
Zaslaver et al., 2001). However, these studies have not fo-
cused on later events such as endosome motility or recy-
cling. Studies using drugs that depolymerize actin filaments
implicate actin at a recycling step (Durrbach et al., 1996; Cao
et al., 1999; Zaslaver et al., 2001; Sheff et al., 2002). Further-
more, mutations or deletions of myosin subtypes associated
with early endosomes specifically alter recycling from early
endosomal compartments, further suggesting a role for actin
in the motility of endocytic vesicles at a recycling step (Neu-
haus and Soldati, 2000; Lapierre et al., 2001). Our data sug-
gest a specific role for the CART complex in endosomal
motility as well as a molecular mechanism linking endo-
somes to actin filaments essential for a particular step in the
endocytic pathway. We propose that the CART complex
facilitates recycling of molecules that are internalized and
recycled by a constitutive, but not a ligand-induced, mech-
anism.
There are three myosin V family members in mammals
(Mercer et al., 1991; Zhao et al., 1996; Rodriguez and Cheney,
2002) that have been implicated in genetic diseases and
membrane trafficking (Mooseker and Cheney, 1995; Hasson
and Mooseker, 1996; Titus, 1997). A role for myosin Vb in
endocytic trafficking, specifically at a recycling step (Lapi-
erre et al., 2001; Volpicelli et al., 2002), has been suggested
based on the ability of the myosin Vb tail domain to retard
recycling of the M4 muscarinic acetylcholine receptor (Vol-
picelli et al., 2002) and the Tf receptor (Lapierre et al., 2001)
and to result in the accumulation of Tf in pericentriolar
vesicles (but see Provance et al., 2004). Overexpression of tail
fragments prevents binding of the myosin to its cargo, dis-
engaging it from actin. The model proposed for the role of
myosin Va in melanosome transport (Gross et al., 2002)
suggests that retrograde microtubule-based transport by dy-
nein antagonizes anterograde transport by kinesin. Myosin
V contributes to anterograde transport by capturing mela-
nosomes in the cell periphery. Similar models have been
proposed for chromaffin cell exocytosis (Rose et al., 2003)
and for vesicle transport in neurons (Bridgman, 1999). The
slow recycling kinetics and the pericentriolar localization of
Tf when actinin-4 is depleted or when the hrs/actinin-4,
actinin-4/BERP, or BERP/myosin V interactions are dis-
rupted are consistent with this model.
The association of endocytic organelles with cytoskeletal
networks would allow guided vesicular trafficking to sub-
sequent cellular compartments. The complementary roles
played by the actin cytoskeleton and microtubule network
in the endocytic pathway (van Deurs et al., 1995; Durrbach et
al., 1996; Maples et al., 1997; Murray et al., 2000) suggest that
endosomes contain proteins allowing for movement on both
types of cytoskeletal network. Small GTPases of the rab
family have been suggested to be required for endosome
motility and recycling. For example, rab5a is present on
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endosomes, is involved in endosome-endosome fusion
(Gournier et al., 1998), in linking early endosomes to micro-
tubules, and in minus-end–directed movement (Nielsen et
al., 1999), although rab5a has not yet been demonstrated to
interact with any motor protein. Rab 4 and rab 11 are endo-
some-associated proteins thought to be involved in recycling
(Van Der Sluijs et al., 1991; McCaffrey et al., 2001; Lindsay
and McCaffrey, 2002; Peden et al., 2004) but their precise
roles and which of the many possible effectors are relevant
for this function remains unclear (Nagelkerken et al., 2000;
Cormont et al., 2001; van der Sluijs et al., 2001; Lindsay et al.,
2002; Fouraux et al., 2004; Peden et al., 2004). The present
data suggest that hrs may link endosomes to actin through
actinin-4, BERP, and myosin Vb. Thus, rab 4, 5, and 11
proteins and hrs can associate with endosomal vesicles and
may be involved in sequential stages of endosomal motility/
maturation. For example, rab5 may allow for microtubule-
dependent trafficking of early endosomes, whereas hrs is
involved in actin-based trafficking and has a specific role in
recycling from the early endosome.
Our proposal for a role of hrs in endosomal recycling is
consistent with data showing that inactivation of its yeast
ortholog, Vps27p, results in accumulation of both recycling
Golgi proteins and endocytosed proteins in a class E com-
partment and suggests a generalized role of this protein and
other class E proteins in endosomal recycling (Piper et al.,
1995). The role of hrs in endosomal recycling is not incon-
sistent with a hypothesis suggesting that hrs or Vps27p
functions in endocytic protein sorting (Katzmann et al., 2001;
Bilodeau et al., 2002; Lloyd et al., 2002) and in early endo-
some fusion (Sun et al., 2003). These studies have suggested
that hrs/Vps27p is linked with proteins required for the
ubiquitination and sorting of cargo (Katzmann et al., 2001;
Bilodeau et al., 2002) and that hrs inhibits homotypic early
endosome fusion (Sun et al., 2003). Hrs/Vps27p may bind
ubiquitinated cargo with its UIM domain (Bilodeau et al.,
2002; Polo et al., 2002; Shih et al., 2002), which is required for
its cargo sorting function because mutation of that domain
blocks sorting of ubiquitinated cargo proteins (Bilodeau et
al., 2002; Shih et al., 2002). The endosomal sorting function
also has been hypothesized to require a protein complex
called ESCRT I (Katzmann et al., 2001). Hrs has been sug-
gested to recruit the ESCRT 1 complex to early endosomes.
The role of hrs in recruiting sorting or signaling components
to the endosomal membrane likely is a function of a number
of factors, including its oligomerization (Bean et al., 1997)
and/or competition among binding proteins (Bean et al.,
2000). Therefore, hrs may bind to an endosomal receptor,
SNAP-25, by using its Q-SNARE domain and inhibit endo-
somal fusion (Sun et al., 2003), whereas it is involved in cargo
sorting and/or endosome motility using N-terminal VHS,
FYVE, or UIM domains or via actinin-4 interactions. Thus, a
sorting step might occur before, or coincident with, the
inhibition of fusion. Subsequently, if endosomes destined
for different cellular destinations used a diverse assortment
of molecules to associate with various cytoskeletal elements,
this would allow them to achieve the sorting and distinct
routing required for separating receptors to be recycled from
those to be degraded.
We have presented a model for the role of the CART
complex and the actin cytoskeleton in endosome recycling
(Figure 6). Because much of hrs is cytosolic, it likely cycles
on and off the early endosomal membrane (Komada et al.,
1997; Tsujimoto et al., 1999), perhaps via binding to a protein
receptor (Figure 6, step 1), before binding actinin-4. Our data
suggest a sequential association of complex components
such that once the actinin-4 has bound hrs, BERP may bind,
followed by myosin V although subcomplexes may form
and unite. Association of the endosomal CART complex
with actin filaments would facilitate rapid movement of the
Figure 6. Model of how Tf-containing recycling endosomes may
link to actin filaments via the CART complex. (A) Recombinant
protein binding experiments suggest that there is an ordered assem-
bly for the complex: 1) hrs binds to actinin-4; 2) BERP binds to
hrs/actinin-4; and 3) myosin V binds to hrs/actinin-4/BERP. BERP
has been shown to bind to myosin V via its tail domain, whereas
myosin V binds to actin filaments and moves processively via its
head domain. Actinin-4 binds to BERP in its C-terminal region and
to hrs in the region after the EF hands. The quaternary complex
could bind to actin filaments or the tertiary hrs/actinin-4/BERP
complex might bind to myosin V already attached to actin filaments.
(B) Model for the role of the CART complex and the actin cytoskel-
eton in endosome recycling. Because much of hrs is cytosolic, it
likely cycles on and off the early endosomal membrane (Komada et
al., 1997; Tsujimoto et al., 1999), perhaps via binding to a protein
receptor (SNAP-25, step a), before actinin-4 binding. This would
occur after, or coincident with, endosomal sorting of Tf-R (step 1).
Once the hrs/actinin-4 complex was formed, association with BERP
and myosin V would facilitate rapid movement of Tf-R-enriched
endosomes back to the plasma membrane on actin filaments. The
majority of EGF receptor would bypass this recycling step (step 2)
after ligand-induced internalization and would instead travel
through the MVB en route to the lysosome for degradation. A
minority of EGF receptor would recycle to the plasma membrane
(from the MVB or recycling endosome) along with a fraction of the
Tf receptor (through the recycling endosome), in CART complex-
independent pathways.
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endosome back to the plasma membrane. The majority of
EGF receptor would bypass this recycling step (Figure 6,
step 2) after ligand-induced internalization and would in-
stead travel through the multivesicular body (MVB) en route
to the lysosome for degradation. A minority of EGF receptor
would recycle to the plasma membrane (from the MVB or
recycling endosome) along with some Tf receptor (through
the recycling endosome), in slower CART complex-indepen-
dent pathways. The large number and varied function of
molecules that undergo constitutive endocytosis suggests
that the CART molecular interaction may be critical for
many cellular functions.
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